SCHEMBL17675332

SCHEMBL17675332

Nc1ccc2ncnc(Oc3ccc(C(=O)Nc4ccccn4)cc3)c2c1

nearest known ligand 0.70

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
BTK Q06187 8/20 0.70
EGFR P00533 6/20 0.70
CSF1R P07333 2/20 0.53
F2 P00734 1/20 0.52
NPC1 O15118 5/20 0.51
RAB9A P51151 5/20 0.51
CHRNB2 P17787 1/20 0.47
CHRNB4 P30926 1/20 0.47
CHRNA3 P32297 1/20 0.47
CHRNA4 P43681 1/20 0.47
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
KDR P35968 1/20 0.44
KDM4E B2RXH2 1/20 0.44
ALDH1A1 P00352 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
LMNA P02545 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17683820 0.85 BTK (0.77) BTKEGFRCSF1RF2NPC1
SCHEMBL17675235 0.84 BTK (0.73) BTKEGFRF2NPC1RAB9A
SCHEMBL17675311 0.84 BTK (0.66) BTKEGFRF2NPC1RAB9A
SCHEMBL17675208 0.84 BTK (0.56) BTKEGFRCSF1RNPC1RAB9A
SCHEMBL17675462 0.84 BTK (0.51) BTKEGFRCSF1RKDR
SCHEMBL17675474 0.84 BTK (0.60) BTKEGFRCSF1RF2KDR
SCHEMBL17675434 0.83 EGFR (1.00) BTKEGFRF2CHRNB2CHRNB4
SCHEMBL17675188 0.81 EGFR (0.74) BTKEGFRNPC1RAB9A
Trifluoroacetic Acid SCHEMBL17675534 0.80 BTK (0.69) BTKEGFRCSF1RF2KDR
SCHEMBL17683840 0.79 BTK (0.79) BTKEGFRCSF1RF2KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016055982-A1 QUINOLINE AND QUINAZOLINE COMPOUNDS ACERTA PHARMA B.V. (NL) 2016-04-14 WO disclosed
WO-2016055982-A1 QUINOLINE AND QUINAZOLINE COMPOUNDS ACERTA PHARMA B.V. (NL) 2016-04-14 WO disclosed